The global virtual reality neuropsychological therapy market accounted for USD 0.779 billion in 2023 and is expected to reach at USD 13.99 billion by 2034 with a CAGR of 30.03% during the forecast period 2024-2034. The market will grow as a result of factors such as the rising prevalence of neuropsychological disorders, advancements in virtual reality technology, growing awareness and acceptance, a shortage of healthcare professionals, personalized and adaptive therapy, rising investment, and increased collaboration.
The potential advantages of virtual reality therapy in cognitive rehabilitation are becoming more widely known to patients and healthcare practitioners. Virtual reality (VR) is becoming more widely accepted as a common therapeutic tool as more studies show its effectiveness and safety. For instance, MindMaze and Microsoft collaborated to create a new VR platform for cognitive evaluation and therapy in April 2022.
By technology, the fully immersive VR segment accounted for the highest revenue-grossing segment in the global virtual reality neuropsychological therapy market in 2023 owing to the high level of immersion and engagement it offers, leading to better therapeutic outcomes and patient satisfaction compared to other VR modalities. For instance, Psious received FDA 510(k) authorization in February 2024 for their VR therapy program to treat adult anxiety disorders. Additionally, the semi-immersive VR segment is predicted to grow at the fastest CAGR during the forecast period owing to the increasing affordability and accessibility of semi-immersive VR systems, making them more widely adopted across various healthcare settings and enabling greater scalability of neuropsychological therapy programs.
By offering, the software segment accounted for the highest revenue-grossing segment in the global virtual reality neuropsychological therapy market in 2023 owing to the customization options, continual updates, and compatibility with a wide range of VR hardware, offering flexibility and tailored solutions to meet the diverse needs of healthcare providers and patients. For instance, Psious received FDA 510(k) authorization in February 2024 for their VR therapy program to treat adult anxiety disorders. Additionally, the services segment is predicted to grow at the fastest CAGR during the forecast period owing to the increased demand for personalized therapy programs, training, and technical support services, driving the adoption of virtual reality neuropsychological therapy solutions across healthcare facilities worldwide.
By end-user, the hospitals and clinics segment accounted for the highest revenue-grossing segment in the global virtual reality neuropsychological therapy market in 2023 owing to the increasing integration of VR technology into traditional healthcare settings, expanding accessibility of neuropsychological therapy services to a wider patient population within hospital and clinic environments. For instance, in January 2024, a study conducted by Limbix and published in the American Journal of Psychiatry showed how well its VR therapy program worked in treating PTSD in veterans of the armed forces. Additionally, the others segment is predicted to grow at the fastest CAGR during the forecast period owing to the rising adoption of virtual reality neuropsychological therapy solutions in non-traditional settings such as rehabilitation centers, research institutions, and educational facilities, driven by evolving treatment paradigms and expanding applications of VR technology.
North American region is anticipated to have the highest revenue share during the forecast period owing to the established healthcare infrastructure, high adoption of advanced technologies, strong presence of key market players, and increasing investments in research and development initiatives aimed at enhancing virtual reality neuropsychological therapy outcomes. Additionally, the Asia Pacific region is predicted to grow at the fastest CAGR during the forecast period owing to the rapidly expanding healthcare infrastructure, increasing awareness about neuropsychological disorders, growing acceptance of virtual reality technology, and rising investments in healthcare IT across emerging economies in the region. For instance, Firsthand Technology introduced a new virtual reality therapy program in December 2023 that is intended to address phobias including the fear of heights and public speaking.
This extensive research report concentrates on the size and projections of the global and regional markets from 2023 to 2034.
The potential advantages of virtual reality therapy in cognitive rehabilitation are becoming more widely known to patients and healthcare practitioners. Virtual reality (VR) is becoming more widely accepted as a common therapeutic tool as more studies show its effectiveness and safety. For instance, MindMaze and Microsoft collaborated to create a new VR platform for cognitive evaluation and therapy in April 2022.
By technology, the fully immersive VR segment accounted for the highest revenue-grossing segment in the global virtual reality neuropsychological therapy market in 2023 owing to the high level of immersion and engagement it offers, leading to better therapeutic outcomes and patient satisfaction compared to other VR modalities. For instance, Psious received FDA 510(k) authorization in February 2024 for their VR therapy program to treat adult anxiety disorders. Additionally, the semi-immersive VR segment is predicted to grow at the fastest CAGR during the forecast period owing to the increasing affordability and accessibility of semi-immersive VR systems, making them more widely adopted across various healthcare settings and enabling greater scalability of neuropsychological therapy programs.
By offering, the software segment accounted for the highest revenue-grossing segment in the global virtual reality neuropsychological therapy market in 2023 owing to the customization options, continual updates, and compatibility with a wide range of VR hardware, offering flexibility and tailored solutions to meet the diverse needs of healthcare providers and patients. For instance, Psious received FDA 510(k) authorization in February 2024 for their VR therapy program to treat adult anxiety disorders. Additionally, the services segment is predicted to grow at the fastest CAGR during the forecast period owing to the increased demand for personalized therapy programs, training, and technical support services, driving the adoption of virtual reality neuropsychological therapy solutions across healthcare facilities worldwide.
By end-user, the hospitals and clinics segment accounted for the highest revenue-grossing segment in the global virtual reality neuropsychological therapy market in 2023 owing to the increasing integration of VR technology into traditional healthcare settings, expanding accessibility of neuropsychological therapy services to a wider patient population within hospital and clinic environments. For instance, in January 2024, a study conducted by Limbix and published in the American Journal of Psychiatry showed how well its VR therapy program worked in treating PTSD in veterans of the armed forces. Additionally, the others segment is predicted to grow at the fastest CAGR during the forecast period owing to the rising adoption of virtual reality neuropsychological therapy solutions in non-traditional settings such as rehabilitation centers, research institutions, and educational facilities, driven by evolving treatment paradigms and expanding applications of VR technology.
North American region is anticipated to have the highest revenue share during the forecast period owing to the established healthcare infrastructure, high adoption of advanced technologies, strong presence of key market players, and increasing investments in research and development initiatives aimed at enhancing virtual reality neuropsychological therapy outcomes. Additionally, the Asia Pacific region is predicted to grow at the fastest CAGR during the forecast period owing to the rapidly expanding healthcare infrastructure, increasing awareness about neuropsychological disorders, growing acceptance of virtual reality technology, and rising investments in healthcare IT across emerging economies in the region. For instance, Firsthand Technology introduced a new virtual reality therapy program in December 2023 that is intended to address phobias including the fear of heights and public speaking.
This extensive research report concentrates on the size and projections of the global and regional markets from 2023 to 2034.
Report Scope:
- Base Year: 2023
- Forecast Period: 2024-2034
- Study Coverage
- Market Forecast by Technology, Offering, and End-User
- Market Forecast for 5 Regions and 17+ Countries
- North America (U.S. and Canada)
- Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
- Asia Pacific (China, Japan, India, Australia, South Korea, Rest of APAC)
- Latin America (Brazil, Mexico, Argentina, Rest of LATAM)
- MEA (South Africa, GCC, Rest of MEA)
- Exhaustive Company Profiles of the Top 10+ Major Market Players
Segmentation: Virtual Reality Neuropsychological Therapy Market Report 2023 - 2034
Virtual Reality Neuropsychological Therapy Market Analysis & Forecast by Technology 2023 - 2034 (Revenue USD Bn)
- Full Immersive VR
- Semi-Immersive VR
- Non-Immersive VR
Virtual Reality Neuropsychological Therapy Market Analysis & Forecast by Offering 2023 - 2034 (Revenue USD Bn)
- Hardware Devices
- Software
- Services
Virtual Reality Neuropsychological Therapy Market Analysis & Forecast by End-User 2023 - 2034 (Revenue USD Bn)
- Hospitals
- Clinics
- Surgical Centers
- Diagnostic Laboratories
- Healthcare Institutes
- Others
Virtual Reality Neuropsychological Therapy Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn)
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
- Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Table of Contents
1. Research Methodology
2. Introduction
4. Market Environment Analysis
5. Market Dynamics
7. Virtual Reality Neuropsychological Therapy Market: Technology Estimates & Trend Analysis
8. Virtual Reality Neuropsychological Therapy Market: Offering Estimates & Trend Analysis
9. Virtual Reality Neuropsychological Therapy Market: End-User Estimates & Trend Analysis
10. Regional Market Analysis
11. North America Virtual Reality Neuropsychological Therapy Market
12. Europe Global Virtual Reality Neuropsychological Therapy Market
13. Asia Pacific Global Virtual Reality Neuropsychological Therapy Market
14. Latin America Global Virtual Reality Neuropsychological Therapy Market
15. MEA Global Virtual Reality Neuropsychological Therapy Market
16. Competitor Analysis
17. Company Profiles
Companies Mentioned
- Oculus VR (Facebook Technologies LLC)
- MindMaze
- Psious
- XRHealth (formerly VRHealth)
- Limbix
- Samsung Electronics Co. Ltd. (Samsung Gear VR)
- Firsthand Technology
- AppliedVR
- Osso VR
- CognifiSense
- Virtually Better Inc.
- Neuro Rehab VR
- Virti
- ImmersiveTouch Inc.
- BehaVR.
